At the end of treatment-free intervals up to 80 days, patients with atopic dermatitis treated with tapinarof maintained low disease level.

A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to ...

Lebrikizumab is comparable or superior to many advanced systemic monotherapies for the short-term treatment of atopic dermatitis.

Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...

Once-daily roflumilast cream 0.05 percent is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 ye ...

A 66-year-old man was referred to our dermatology clinic for a 6-year history of a progressive pruritic rash, refractory to prescribed treatments. On examination, he had widespread follicular papules ...

Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease ...